Demo Sign up Log In

Anika Therapeutics Inc (ANIK)

R&D Expenses

$7.34M

Quarterly · Period ending: Jun 30, 2026 · USD

ANIK R&D Expenses

Latest reported$7.34Mperiod endingJun 30, 2026

Latest reported$7.34Mperiod endingJun 30, 2026

ANIK Quarterly R&D Expenses ($0.00 → $7.34M)

Quarterly R&D Expenses

High-resolution chart · PNG

ANIK r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	921,325
Mar 31, 2001	1,347,870
Dec 31, 2000	522,848
Sep 30, 2000	516,171
Jun 30, 2000	907,227
Mar 31, 2000	1,313,738
Dec 31, 1999	1,400,000
Sep 30, 1999	1,200,000
Jun 30, 1999	900,000
Mar 31, 1999	700,000
Dec 31, 1998	600,000
Sep 30, 1998	500,000
Jun 30, 1998	400,000
Mar 31, 1998	500,000
Dec 31, 1997	500,000
Sep 30, 1997	600,000
Jun 30, 1997	500,000
Mar 31, 1997	300,000
Nov 30, 1996	600,000
Aug 31, 1996	500,000
May 31, 1996	500,000
Feb 29, 1996	400,000
Nov 30, 1995	300,000
Aug 31, 1995	400,000
May 31, 1995	300,000
Feb 28, 1995	300,000
Nov 30, 1994	400,000
Aug 31, 1994	400,000
May 31, 1994	400,000
Feb 28, 1994	400,000
Nov 30, 1993	0
Aug 31, 1993	0
May 31, 1993	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.